PC(16:1(9Z)/18:3(6Z,9Z,12Z))

Metabolite details

Identifier

ZZLFVAJFRYBVSN-URBNVOGLSA-N

InChI Key

ZZLFVAJFRYBVSN-URBNVOGLSA-N

IUPAC name

Preferred name

PC(16:1(9Z)/18:3(6Z,9Z,12Z))

INN name

—

Synonym

(2-{[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

ChEBI

CHEBI:89732

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Normal_control_no_tumor_vs_FH_deficient_RCC